A newly finalized guidance document from the US Food and Drug Administration details the agency’s preferred approach to ensuring compliance with informed consent guidelines during device and drug clinical trials.
“Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors” addresses basic elements of informed consent, including how to describe the study, explain potential risks and benefits, and discuss compensation...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?